S2312 CARAVAN
Prostate Cancer
A Phase III Study of Cabazitaxel with or without Carboplatin in Patients with Metastatic Castrate-resistant Prostate Cancer (MCRPC), Stratified By Aggressive Variant Signature.
Accepting Patients
Enrollment Started: April 29, 2025





